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ER-stress induced apoptosis of beta cells is an important
mechanism of type 2 diabetes. PERK can be activated by
the overactivation of ER-stress which will induce beta
cells apoptosis. This study is to reveal the role of ER-
stress, GSK-3 and the potential signal pathway during
beta cells apoptosis.
The alterations of ER-stress related signal factors and
kinases induced by OA are assessed by western blot, and
the changes of PERK and AMPK are analyzed by ELISA
meanwhile. The phosphorylated GSK-3b and total GSK-3
are detected by western blot, while PERK are inhibited by
the transfection of P58IPK plasmid and AMPK are inhib-
ited by the inhibitor Compound C. Finally, the interaction
between PERK and GSK-3 are identified by co- immuno-
precipitation and direct immuno-fluorescence. The study
shows 1. The expression of GRP78, ATF6, XBP1, PERK
and AMPK significant increased in the presence of 0.4mM
OA(P<0.01) after OA treatment. 2. Activity of PERK and
AMPK significantly augmented in the presence of OA
(P<0.01). 3. Detections of the alterations of GSK-3 after
inhibiting the activity of PERK and AMPK shows (1) GSK-
3b was activated when treated with OA; (2) the phosphor-
ylation of GSK-3b obviously increased after the inhibition
of PERK by transfection of P58IPK plasmid (P<0.01); (3)
the activity of GSK-3 had no change after the inhibition of
AMPK by Compound C.(P>0.05). 4. Co-immunoprecipita-
tion of PERK and GSK-3 verified the association of PERK
and GSK-3. 5. Obvious co-localization was observed after
merging FITC-conjugated PERK and Rhodamine-conju-
gated GSK-3b. These results suggest activation of GSK-3
can induce beta cells apoptosis by ER-stress which is
caused after long-time exposure to free fatty acids. PERK
will activate GSK-3 directly. Collectively, PERK-GSK-3 sig-
nal pathway will play an important role during beta cell
apoptosis in type 2 DM.
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